Malawi-Liverpool-Wellcome Clinical Research Programme, Blantyre, Malawi.
J Infect Dis. 2011 Aug 1;204(3):358-62. doi: 10.1093/infdis/jir265.
Up to 14% of Malawian adults die during the intensive phase of tuberculosis treatment. In a prospective cohort of 199 Malawian adults with microbiologically confirmed pulmonary tuberculosis, clinical and laboratory parameters were compared between those who died or deteriorated with those who had an uneventful recovery. Baseline tumor necrosis factor alpha responses to stimulation with heat-killed Mycobacterium tuberculosis and lipopolysaccharide were reduced among the 22 patients with poor outcome (P = .017). Low body mass index (P = .002) and elevated respiratory rate (P = .01) at tuberculosis diagnosis independently predicted poor outcome. Validation of a clinical score identifying high-risk individuals is warranted, together with further investigation of immunological derangements.
多达 14%的马拉维成年人在结核病强化治疗期间死亡。在一项前瞻性队列研究中,199 名经微生物学证实的肺结核马拉维成年人中,对死亡或恶化的患者与无并发症恢复的患者进行了临床和实验室参数比较。在 22 名预后不良的患者中,刺激热灭活结核分枝杆菌和脂多糖后肿瘤坏死因子 α 的反应降低(P=0.017)。低体重指数(P=0.002)和较高的呼吸频率(P=0.01)在结核病诊断时独立预测预后不良。需要验证一种能够识别高危个体的临床评分,同时还需要进一步研究免疫紊乱。